HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hisakazu Ogita Selected Research

epithelial membrane protein-1

10/2021Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment.
10/2018Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hisakazu Ogita Research Topics

Disease

11Neoplasms (Cancer)
10/2021 - 08/2008
7Cardiomegaly (Heart Hypertrophy)
11/2017 - 09/2002
6Myocardial Ischemia (Ischemic Heart Diseases)
05/2007 - 07/2002
5Heart Failure
11/2017 - 01/2003
5Infarction (Infarctions)
06/2004 - 01/2002
5Reperfusion Injury
06/2004 - 01/2002
4Ischemia
06/2004 - 01/2002
4Hypertrophy
02/2004 - 09/2002
3Neoplasm Metastasis (Metastasis)
10/2021 - 10/2018
3Color Vision Defects (Color Blindness)
12/2016 - 07/2012
3Coronary Occlusion
09/2003 - 01/2002
2Fibrosis (Cirrhosis)
11/2017 - 01/2017
2Hypertension (High Blood Pressure)
01/2016 - 03/2004
2Myocardial Infarction
06/2003 - 01/2002
2Body Weight (Weight, Body)
01/2003 - 09/2002
2Ventricular Fibrillation
09/2002 - 01/2002
1Kallmann Syndrome (Kallmann's Syndrome)
01/2020
1Anosmia
01/2020
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2020
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2020
1Brugada Syndrome
01/2020
1Atrial Fibrillation
01/2019
1Bradycardia
01/2019
1Prostatic Neoplasms (Prostate Cancer)
10/2018
1Hepatocellular Carcinoma (Hepatoma)
04/2018
1Left Ventricular Dysfunction
11/2017
1Inflammation (Inflammations)
01/2016
1Retinoblastoma (Glioblastoma, Retinal)
09/2015
1Pathologic Neovascularization
01/2015
1Atherosclerosis
01/2014
1Edema (Dropsy)
01/2013
1Osteosarcoma (Osteogenic Sarcoma)
10/2012
1Herpes Zoster
06/2008
1Starvation
06/2008

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2002
5NG-Nitroarginine Methyl Ester (L-NAME)IBA
06/2003 - 01/2002
5Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2003 - 01/2002
4afadinIBA
11/2017 - 06/2008
4Selective Estrogen Receptor Modulators (SERM)IBA
06/2004 - 01/2002
4Raloxifene Hydrochloride (Evista)FDA Link
06/2004 - 01/2002
3Monomeric GTP-Binding ProteinsIBA
10/2021 - 04/2018
3NectinsIBA
05/2010 - 06/2008
3Immunoglobulins (Immunoglobulin)IBA
05/2010 - 06/2008
3Adenosine (Adenocard)FDA LinkGeneric
06/2004 - 10/2003
35'-Nucleotidase (5' Nucleotidase)IBA
06/2004 - 09/2003
370-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
04/2003 - 09/2002
3Phosphotransferases (Kinase)IBA
01/2003 - 09/2002
2epithelial membrane protein-1IBA
10/2021 - 10/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2018 - 01/2015
2Retinal Pigments (Pigments, Visual)IBA
12/2016 - 07/2012
2asparaginylendopeptidase (legumain)IBA
09/2013 - 01/2013
2Estrogens (Estrogen)FDA Link
06/2007 - 12/2003
2Endothelin-1 (Endothelin 1)IBA
10/2003 - 09/2003
2Charybdotoxin (ChTX)IBA
06/2003 - 09/2002
2Hydralazine (Apresoline)FDA LinkGeneric
01/2003 - 09/2002
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2003 - 09/2002
2Adenosine Triphosphate (ATP)IBA
01/2003 - 09/2002
2PotassiumIBA
01/2003 - 09/2002
2Nitric Oxide Synthase (NO Synthase)IBA
09/2002 - 01/2002
1Biological ProductsIBA
10/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2020
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2020
1Glycoproteins (Glycoprotein)IBA
01/2020
1KetonesIBA
01/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2019
1Potassium Channels (Potassium Channel)IBA
01/2019
1NIP 151IBA
01/2019
1copine IIIIBA
10/2018
1Transcription Factors (Transcription Factor)IBA
04/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2018
1Mevalonic Acid (Mevalonate)IBA
04/2018
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
04/2018
1Growth Differentiation Factor 15IBA
11/2017
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
01/2017
1Cyclic NucleotidesIBA
05/2016
1DNA (Deoxyribonucleic Acid)IBA
05/2016
1dipeptidyl peptidase IIIIBA
01/2016
1AlbuminsIBA
01/2016
1Triiodothyronine (Liothyronine)FDA LinkGeneric
09/2015
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2014
1Peptides (Polypeptides)IBA
10/2012
1CollagenIBA
10/2012
1High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
10/2012
1VitronectinIBA
10/2012
1Cone OpsinsIBA
07/2012
1Messenger RNA (mRNA)IBA
07/2012
1Tyrosine (L-Tyrosine)FDA Link
08/2009
1LigandsIBA
08/2009
1Integrin alphaVbeta3IBA
08/2008
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2008
1ClaudinsIBA
06/2008
1Carrier Proteins (Binding Protein)IBA
06/2008
1Cell Adhesion MoleculesIBA
06/2008
1Cadherins (E-Cadherin)IBA
06/2008
1CateninsIBA
06/2008
1Fas Ligand Protein (Fas Ligand)IBA
06/2008
1Oxygen (Dioxygen)IBA
05/2007
1PEG-hemoglobinIBA
05/2007
1NADPH Oxidases (NAD(P)H oxidase)IBA
05/2006

Therapy/Procedure

5Therapeutics
10/2018 - 12/2003